Clients
HempFusion Gears Up for IPO on the TSX
HempFusion Wellness Inc., a leading health and wellness CBD company, recently closed the order book for its proposed initial public offering (IPO), marking another step closer to becoming a publicly-traded company on the Toronto Stock Exchange (TSX) over the coming months. Completion of this proposed initial public offering has the potential to accelerate the company’s […]
Red White & Bloom Brands Q3 2020 Quarterly Report
December 01, 2020 06:30 ET | Source: Red White & Bloom Brands Inc. Unaudited pro forma revenue, which includes the company’s pending Michigan acquisition of PharmaCo and Completed acquisition of Platinum Vape and assumes the acquisitions had occurred on Jan. 1, 2020, would have been approximately CDN$48-million for the current quarter and CDN$128-million for the nine months ended Sept. 30; Gross […]
Pure Extracts Unveils Plans for Functional Mushrooms
There are more than 2,000 species of edible fungi and at least 15 have functional benefits that support overall health. Like other superfoods, functional mushrooms have antioxidant properties that support the immune system, dietary fiber to aid in healthy digestion and numerous other benefits to everything from mental clarity to skin health. At the […]
HempFusion IPO Order Book Closing
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES HempFusion Wellness Inc. (“HempFusion” or the “Company”) is pleased to announce that, due to demand, it is accelerating the date in which Expressions of Interest (“EOI”) for HempFusion’s proposed IPO will be accepted, to this Friday, November 27th, at 5:00 PM EST. Orders will be accepted on […]
Pure Extracts Advances Plans for the Processing of Functional Mushroom Formulations
VANCOUVER, British Columbia, Nov. 26, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp . (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sectors, is pleased to provide an update and overview regarding its expansion into the functional mushroom wellness sector. […]
Why Focus on Cannabis & Mushroom Extracts?
Cannabis extracts are poised to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. At the same time, the functional mushroom market is forecast to reach $34.3 billion by 2024, which represents a respectable 8% compound annual growth rate. Let’s take a look […]
ManifestSeven: The Importance of Cannabis Distribution
Most cannabis investors are familiar with cultivation operations and dispensaries, but distribution is quickly becoming one of the industry’s most important components. Although distribution plays a big role in other regulated industries, the cannabis industry has only begun recently to recognize the critical role of distributors in the ecosystem. Let’s take a look at […]
Pure Extracts Technologies Corporate Update
VANCOUVER, British Columbia, Nov. 19, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (“Pure Extracts” or the “Company”), began trading on the Canadian Securities Exchange (the “CSE”) on November 5, 2020 under the stock symbol ‘PULL’, and is pleased to provide this corporate update to shareholders and interested investors. About the Company Pure Extracts is a plant-based extraction company specializing […]
CBD Makes Its Way into Mainstream Retail
The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]
How to Invest in the Rise of Cannabis-Infused Beverages
The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry has evolved to provide a growing array of different products, including tinctures, topicals, edibles—and beverages. Let’s […]
Pure Extracts: Recurring Revenue with Blue Sky Potential
The global cannabis extract market is projected to reach $28.5 billion by 2027, according to Grand View Research, representing a 16.6% compound annual growth rate. In addition to the relatively mature cannabis market, the wider market for plant-based extracts could see tremendous growth from the functional mushroom revolution. Let’s take a look at how Pure […]
California Cannabis Industry to Hit $6 Billion by 2025
California’s cannabis industry is on track to surpass $6 billion in 2025, according to BDS Analytics, which would represent a sixth of legal cannabis sales in the United States. Although Nevada and a handful of other states experienced COVID-19-related disruptions, California’s mature market has managed to weather the pandemic thus far. Let’s take a closer […]
Cybin Goes Public on the NEO Exchange
The direct and indirect costs of mental health disorders add up to more than $2.5 trillion worldwide, according to the National Centre for Biotechnology Information. A growing body of research suggests that psychedelics could play a major role in the treatment of these disorders. Not surprisingly, a psychedelics industry has emerged with a number […]
Cybin Goes Public on NEO Exchange
Cybin Inc., a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, participates in a digital market open to celebrate its debut on the global public markets today. Cybin is now trading on the NEO Exchange under the symbol NEO:CYBN. (Photo: Business Wire) November 10, 2020 10:45 AM Eastern Standard Time TORONTO–(BUSINESS […]
MagicMed Industries Announces $2.5 Million Unit Offering Led by Gravitas Securities
CALGARY, AB, Nov. 10, 2020 /CNW/ – MagicMed Industries Inc. (CSE: MGIC reserved) (“MagicMed” or the “Company“) is pleased to announce a proposed offering of up to 5,000,000 units of the Company (the “Units“) at an offering price of $0.50 per Unit (the “Issue Price“), for aggregate gross proceeds of up to $2,500,000 (the “Offering“). The Units will be offered by means of private placement […]
CB Therapeutics: Producing Rare Cannabinoid & Psychedelic Molecules at Scale
The cannabis industry has evolved from the legalization of dried cannabis to an increasingly detailed understanding of individual cannabinoids. While THC and CBD are the two most common, researchers are increasingly interested in CBC, THCV and other rare cannabinoids that could have specific and desirable effects on certain medical indications. The problem is that these […]
ManifestSeven Receives $4.0 Million USD in Note and Warrant Proceeds
Holders of the Company’s convertible notes elect to convert an aggregate of $1.3 million USD November 09, 2020 09:15 AM Eastern Standard Time IRVINE, Calif.–(BUSINESS WIRE)–ManifestSeven Holdings Corporation (CSE:MSVN) (formerly P&P Ventures Inc.) (“M7” or the “Company“) announced today that it has received $2.31 million USD ($3.0 million CAD) from a noteholder in fulfillment of a […]
RWB’s Platinum Vape Continues Growth and Sets Sights on Arizona Recreational Market
TORONTO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to provide an update on Platinum Vape (“Platinum” or “PV”) and comments on Arizona Prop 207. Platinum has continued to execute on its growth plan since closing of the acquisition by […]
Growers vs. Extractors: Where to Invest in Cannabis
Canopy Growth Corp., Tilray Inc. and Aurora Cannabis Inc. are the largest cannabis cultivators in the world, but the shift in consumer preferences from flower to extracts has made cannabis extraction the fastest growing subset of the industry. In fact, MediPharm Labs Corp. and The Valens Company reported revenue of nearly C$14 million and about […]
MagicMed verkürzt die Fristen für die Kommerzialisierung durch Universitätsvertrag
Die meisten Pharma- und Biotech-Investoren sind mit langen Kommerzialisierungsfristen vertraut, aber es gibt einige Möglichkeiten, diese zu verkürzen. Beispielsweise bietet die Food and Drug Administration für bestimmte Therapien, die auf lebensbedrohliche Erkrankungen abzielen, Bezeichnungen wie Fast Track, Durchbruchstherapie, beschleunigte Zulassung und Prioritätsprüfung an. MagicMed Industries Inc., ein Entwickler von lizenzierbaren psychedelischen molekularen Derivaten, verkürzte seinen […]
HempFusion: A Health and Wellness Leader to IPO on the TSX Senior Board
Cannabidiol, better known as CBD, has become one of the fastest growing segments of the health and wellness industry. According to BDS Analytics and ArcView, CBD sales will grow at a 49% compound annual growth rate to exceed $20 billion by 2024. There are very few companies in the sector have the quality, scale and […]
Pure Extracts Begins Trading on the CSE
Cannabis extracts are projected to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. As consumers transition from cannabis flower to oils, tinctures, edibles, topicals and other products, cannabis extraction companies are playing a key role in the next stage of the industry’s […]
ManifestSeven Doubles Revenue, Targets Profitability
ManifestSeven Holdings Corporation (CSE: MSVN) recently reported third-quarter financial results that showed a 96% increase in year-over-year revenue and continued advancement towards net profitability. In particular, quarterly revenue rose 64% to $4.7 million and an adjusted EBITDA loss that decreased 69% to $1.3 million. “In the face of circumstantial challenges as wide-ranging as the continued […]
MagicMed Shortcuts Commercialization Timeline with University Agreement
Most pharmaceutical and biotech investors are familiar with long commercialization timelines, but there are a few ways to shortcut the process. For example, the Food and Drug Administration provides Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review designations for certain therapies targeting life-threatening conditions. MagicMed Industries Inc., a developer of licensable psychedelic molecular derivatives, […]
Pure Extracts Technologies Corp. to Commence Trading on the Canadian Securities Exchange (CSE)
November 03, 2020 12:00 ET | Source: Pure Extract Technologies Corp. VANCOUVER, British Columbia, Nov. 03, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (“Pure Extracts”), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, is pleased to announce that the company’s stock will commence trading on the Canadian Securities Exchange (“CSE”) under the symbol […]
CALGARY, AB, Oct. 30, 2020 – MagicMed Industries Inc. (“MagicMed” or the “Company“) is pleased to announce that it has entered into a Research Contract and a Facilities Use Agreement (“The Agreements”) with the University of Calgary. The Agreements provide MagicMed with further scientific and laboratory support to accelerate development of its psychedelic derivatives patent library, the Psybrary™. “The University of Calgary is excited […]
ManifestSeven Reports Third Quarter 2020 Financial Results
Quarterly and year-to-date revenue respectively up 64% and 96% year-over-year Record revenue and robust growth in cannabis operations Dynamic customer acquisition growth across all operating segments Quarterly operating expenses decreased by 42% year-over-year and 17% sequentially Results continue to advance the Company on its pathway to net profitability October 29, 2020 09:15 AM Eastern Daylight […]
Why Extracts Are Critical for Therapeutics
Many pharmaceuticals are derived from natural sources that have been known to have medicinal properties for years. For example, ephedrine comes from Ephedra sinica and codeine comes from Papaver somniferum. Modern medicine has enhanced these medicinal properties by extracting and synthesizing compounds at far higher concentrations. Let’s take a look at why extraction is critical […]
Christina Lake Cannabis Appoints Ryan Smith as Chief Financial Officer
VANCOUVER, British Columbia, OCTOBER 27, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce the appointment of Ryan Smith as Chief Financial Officer (“CFO”) of the Company. As Controller, Mr. Smith has been responsible for managing the financial actions of the Company. In his previous endeavours, Mr. […]
Just How Big is the Psychedelics Opportunity?
The North American market for psychedelic drugs is projected to reach $6.85 billion by 2027, according to Data Bridge Market Research, which represents a 16.3% compound annual growth rate. After the approval of Johnson & Johnson’s (NYSE: JNJ) SPRAVATO nasal spray for treatment-resistant depression and two Breakthrough Therapy designations, there has been an explosion of […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products.
Geyser Brands Inc builds health-based hemp CBD consumer products in the Nutraceutical, Cosmetics, Food & Beverage and Pet sectors world-wide.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
